NCT02650973View on ClinicalTrials.gov

Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta

PHASE1CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Healthy
Interventions
DRUG

CHS-1701

DRUG

Pegfilgrastim

Trial Locations (4)

45227

Medpace CPU, Cincinnati

53095

Spaulding, West Bend

90630

WCCT, Cypress

Unknown

ICON, San Antonio

Sponsors
All Listed Sponsors
lead

Coherus Oncology, Inc.

INDUSTRY